These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35309331)

  • 21. Identification of prognostic genes in uveal melanoma microenvironment.
    Luo H; Ma C
    PLoS One; 2020; 15(11):e0242263. PubMed ID: 33196683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
    Zhao H; Chen Y; Shen P; Gong L
    Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of immune-related risk signature for uveal melanoma.
    Zhang Z; Ni Y; Chen G; Wei Y; Peng M; Zhang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):912-919. PubMed ID: 32496920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
    Zhang C; Wu S
    Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
    Lei S; Zhang Y
    BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 9-Gene Signature Correlated With CD8
    Yan K; Lu Y; Yan Z; Wang Y
    Front Immunol; 2021; 12():622563. PubMed ID: 34220795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross talk between tumor stemness and microenvironment for prognosis and immunotherapy of uveal melanoma.
    Wan Q; Ren X; Tang J; Ma K; Deng YP
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11951-11968. PubMed ID: 37420017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
    Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
    J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell analysis reveals new evolutionary complexity in uveal melanoma.
    Durante MA; Rodriguez DA; Kurtenbach S; Kuznetsov JN; Sanchez MI; Decatur CL; Snyder H; Feun LG; Livingstone AS; Harbour JW
    Nat Commun; 2020 Jan; 11(1):496. PubMed ID: 31980621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
    Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
    Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment.
    Masaoutis C; Kokkali S; Theocharis S
    Expert Opin Investig Drugs; 2021 May; 30(5):555-569. PubMed ID: 33650931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of gene signature regulation in tumor immune microenvironment on the mechanism of uveal melanoma metastasis.
    Shi K; Tang J; Yuan L; Zhou S; Ran W; Wang Z
    Cancer Biomark; 2023; 36(2):161-175. PubMed ID: 36683494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
    Luo H; Ma C
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.